Thrive Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
22,510
-351
-2% -$81.8K 0.73% 21
2026
Q1
$5.59M Sell
22,861
-1,015
-4% -$236K 0.83% 19
2025
Q4
$4.94M Buy
23,876
+298
+1% +$58.9K 0.73% 21
2025
Q3
$4.37M Sell
23,578
-530
-2% -$90.8K 0.66% 21
2025
Q2
$3.68M Sell
24,108
-129
-0.5% -$19.8K 0.59% 23
2025
Q1
$4.02M Buy
24,237
+1,147
+5% +$179K 0.77% 17
2024
Q4
$3.34M Sell
23,090
-649
-3% -$101K 0.6% 22
2024
Q3
$3.85M Buy
23,739
+189
+0.8% +$30.1K 0.71% 17
2024
Q2
$3.44M Sell
23,550
-968
-4% -$144K 0.67% 19
2024
Q1
$3.88M Buy
24,518
+7,383
+43% +$1.18M 0.8% 14
2023
Q4
$2.69M Sell
17,135
-1,454
-8% -$223K 0.6% 23
2023
Q3
$2.9M Sell
18,589
-229
-1% -$37.8K 0.77% 16
2023
Q2
$3.11M Buy
18,818
+138
+0.7% +$22.3K 0.81% 16
2023
Q1
$2.9M Buy
18,680
+958
+5% +$155K 0.74% 18
2022
Q4
$3.13M Buy
17,722
+648
+4% +$112K 0.9% 19
2022
Q3
$2.79M Buy
17,074
+243
+1% +$41.1K 0.98% 14
2022
Q2
$2.99M Buy
16,831
+1,062
+7% +$189K 1.04% 18
2022
Q1
$2.79M Buy
15,769
+764
+5% +$130K 0.83% 20
2021
Q4
$2.57M Buy
+15,005
New +$2.46M 0.88% 13

Other funds holding JNJ

Thrive Wealth Management's JNJ Position: Q2 2026 in Review

Thrive Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, selling an estimated $81.8K and leaving 22,510 shares worth $5.72M. The position accounts for 0.73% of the portfolio, ranked #21.

Thrive Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Thrive Wealth Management held 22,510 shares of Johnson & Johnson worth $5.72M as of Q2 2026.
  • Thrive Wealth Management sold 351 Johnson & Johnson shares in Q2 2026, an estimated $81.8K.
  • Johnson & Johnson made up 0.73% of Thrive Wealth Management's portfolio in Q2 2026, its #21 holding.
  • Thrive Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Thrive Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.